Flyer

Journal of Neurology and Neuroscience

  • ISSN: 2171-6625
  • Journal h-index: 18
  • Journal CiteScore: 4.35
  • Journal Impact Factor: 3.75
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • The Global Impact Factor (GIF)
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Scientific Journal Impact Factor (SJIF)
  • Euro Pub
  • Google Scholar
  • Secret Search Engine Labs
Share This Page

Abstract

Uveitis and Acute Myelitis after COVID-19

Narjes Gouta*, Mariem Mhiri, Rihab Ben Dhia, Mouna Aissi and Mahbouba Frih-Ayed

A number of neurological disorders have been reported to be associated with the novel corona virus (COVID-19) including acute stroke, encephalitis, convulsions, peripheral neuropathy and rarely myelitis. Multiple other symptoms have been reported such as uveitis. In this article we presented the case of a 32-year-oldwoman who was presented to hospital with proprioceptive ataxic walking, progressive lower limb weakness, urinary retention and visual blur. She had been diagnosed with COVID-19 four days before the appearance of symptoms. Clinical examination showed weakness, hyporeflexia, hypoaesthesia of both lower limbs and intermediate uveitis. The evolution was marked by the total regression of the motor deficit and partial regression of the visual blur after treatment with intravenous methylprednisone. It is important to recognize potential neurologic manifestations and complications of the noval corona virus especially when some of which can be rapidly progressing and require urgent intervention.

Published Date: 2022-02-23; Received Date: 2022-01-16